Peripheral blood indices in women with development of ovarian hyperstimulation syndrome

  • O. F. Bekasova Zaporizhzhya National University
  • N. V. Avramenko Zaporizhzhia State Medical University
  • O. V. Kabachenko Zaporizhzhia State Medical University
  • K. D. Ivanova Zaporizhzhya National University
  • V. V. Kopiika Zaporizhzhya National University
Keywords: assisted reproductive technology, systemic inflammatory response syndrome, blood, hematological parameters of the blood, blood biochemical parameters, blood clotting tests

Abstract

Ovarian hyperstimulation syndrome (OHSS) occurs in practice as a complication in vitro fertilization. The risk of a negative result for embryo transfers significantly increased at OHSS. The search for early markers of OHSS development is relevant. The aim of this study is to identify predictors of moderate OHSS. We analyzed data of young and middle-aged women
(20-45 years) before and after hormonal therapy, divided into two groups: 1) without signs the development of OHSS; 2) with initial clinical signs of mild OHSS. We determined hematological parameters (white cell count, red blood cell count, thrombocytes count, white blood cell differential, the erythrocyte sedimentation rate (ESR) and the level of hemoglobin), biochemical parameters (blood test of total protein, the glucose, the creatinine, the alanine aminotransferase and aspartate aminotransferase (ALAT and ASAT, respectively), K , Na ) and coagulometry (the thrombin time, the prothrombin time, fibrinogen, the partial thromboplastin time) of peripheral blood. Statistical analysis consisted of comparing the performance of two research groups using the Mann-Whitney U-test. Significant differences achieved between parameters ESR, ALAT, ASAT and a total protein test in the group with OHSS after removal of mature follicles compared with indicators before puncture and the group without signs of OHSS after follicle puncture. According to literature data these characteristics are out of the range in women with severe OHSS, while follow to our results, only the ESR parameter significantly increased in the group with OHSS. But other serum characteristics were in the normal range, indicating the presence in women of moderate OHSS. ESR, aminotransferase and total protein can potentially use in predicting moderate OHSS in combination with other characteristics.

References

ЛІТЕРАТУРА
(1) Chakravarthi, I. Regulation of Assisted Reproductive Technologies: Gains and Losses. Indian J. Gend. Stud. 2016, 23 (1), 133–156. https://doi.org/10.1177/0971521515612866.
(2) Smith, V.; Osianlis, T.; Vollenhoven, B. Prevention of Ovarian Hyperstimulation Syndrome. Obstet. Gynecol. Int. 2015, 2015, pp 1-10. https://doi.org/10.1155/2015/514159.
(3) Gurbuz, A. S.; Calik, M.; Ozcimen, E. E.; Ozcimen, N.; Calik, S. G. Ovarian Hyperstimulation Syndrome: A Rare Case of Unilateral Pleural Effusion. J. Emerg. Med. Case Reports 2016, 7 (4), рр 74-76. https://doi.org/10.5152/jemcr.2016.1502.
(4) Gichuhi, J. W.; Wanyoike, S. W.; Ndegwa, S. Ovarian Hyperstimulation Syndrome (OHSS): Case Report. East Afr. Med. J. 2015, 92 (1), рр 39-42.
(5) Corbett, S.; Shmorgun, D.; Claman, P.; Cheung, A.; Sierra, S.; Carranza-Mamane, B.; Case, A.; Dwyer, C.; Graham, J.; Havelock, J.; et al. The Prevention of Ovarian Hyperstimulation Syndrome. J. Obstet. Gynaecol. Canada 2014, 36 (11), pp 1024-1033. https://doi.org/10.1016/S1701-2163(15)30417-5.
(6) Marak, C. P.; Chopra, A.; Alappan, N.; Ponea, A. M.; Guddati, A. K. Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy. Case Rep. Obs. Gynecol 2013, 2013, pp 1-3. https://doi.org/10.1155/2013/653704.
(7) Stolorz, K.; Nowosielski, K.; Wlodarz, Izabela Ulman Sodowska, P.; Sodowski, K. Ovarian Hyperstimulation Syndrome in Spontaneous Pregnancy. J Gynecol Res Obs. 2016, 2 (1), рр 5-9.
(8) Bulavenko, O.; Konkov, D.; Burtyak, N. Ovarian Hyperstimulation Syndrome. The New Approaches for Diagnosis, Treatment and Prevention. Вісник морфології 2015, 21 (2),
c 525-531.
(9) Alper, M. M.; Smith, L. P.; Sills, E. S. Ovarian Hyperstimulation Syndrome: Current Views on Pathophysiology, Risk Factors, Prevention, and Management. J. Exp. Clin. Assist. Reprod. 2009, 3 (6), pp 1-7.
(10) Fouda, U. M.; Sayed, A. M.; Elshaer, H. S.; Hammad, B. E. M.; Shaban, M. M.; Elsetohy, K. A.; Youssef, M. A. GnRH Antagonist Rescue Protocol Combined with Cabergoline versus Cabergoline Alone in the Prevention of Ovarian Hyperstimulation Syndrome: A Randomized Controlled Trial. J. Ovarian Res. 2016, 9 (1), рр 1-8. https://doi.org/10.1186/s13048-016-0237-8.
(11) Nastri, C. O.; Ferriani, R. A.; Rocha, I. A.; Martins, W. P. Ovarian Hyperstimulation Syndrome: Pathophysiology and Prevention. J. Assist. Reprod. Genet. 2010, 27, pp 121-128. https://doi.org/10.1007/s10815-010-9387-6.
(12) Mai, Q.; Hu, X.; Yang, G.; Luo, Y.; Huang, K.; Yuan, Y.; Zhou, C. Effect of Letrozole on Moderate and Severe Early-Onset Ovarian Hyperstimulation Syndrome in High-Risk Women: A Prospective Randomized Trial. Am. J. Obstet. Gynecol. 2017, 216 (1), pp 42.e1-42.e10. https://doi.org/10.1016/j.ajog.2016.08.018.
(13) Aiziatulova, E. M. Secondary Predictors of Ovarian Hyperstimulation Syndrome Development. Zaporozhye Med. J. 2019, 0 (6), рр 770-775. https://doi.org/10.14739/2310-1210.2019.6.186502.
(14) Kim, J.; Steiner, A. Z.; Fritz, M.; Mersereau, J. E. Severe Ovarian Hyperstimulation Syndrome after Letrozole-Gonadotropin Stimulation: A Case Report. J. Assist. Reprod. Genet. 2012, 29 (2), pp 127-129. https://doi.org/10.1007/s10815-011-9676-8.
(15) Banker, M.; Garcia-Velasco, J. Revisiting Ovarian Hyper Stimulation Syndrome: Towards OHSS Free Clinic. J. Hum. Reprod. Sci. 2015, 8 (1), рр 13-17. https://doi.org/10.4103/0974-1208.153120.
(16) Sansone, P.; Aurilio, C.; Pace, M. C.; Esposito, R.; Passavanti, M. B.; Pota, V.; Pace, L.; Pezzullo, M. G.; Bulletti, C.; Palagiano, A. Intensive Care Treatment of Ovarian Hyperstimulation Syndrome (OHSS). Ann. N. Y. Acad. Sci. 2011, 1221 (1), pp 109-118. https://doi.org/10.1111/j.1749-6632.2011.05983.x.
(17) Goeckenjan, M.; Fischer, D.; Urban, H.; Wimberger, P. Avoiding Ovarian Hyperstimulation Syndrome - Current Primary and Secondary Preventive Strategies. J. Fertil. Vitr. - IVF-Worldwide, Reprod. Med. Genet. Stem Cell Biol. 2016, 4 (4), pp 1-6. https://doi.org/10.4172/2375-4508.1000192.
(18) Cabar, F. R. Ovarian Hyperstimulation Syndrome in a Spontaneous Singleton Pregnancy. Einstein (Sao Paulo). 2016, 14 (2), pp 231-234. https://doi.org/10.1590/S1679-45082016RC3429.
(19) Nastri, C. O.; Teixeira, D. M.; Moroni, R. M.; Leitão, V. M. S.; Martins, W. P. Ovarian Hyperstimulation Syndrome: Pathophysiology, Staging, Prediction and Prevention. Ultrasound Obstet. Gynecol. 2015, 45 (4), pp 377-393. https://doi.org/10.1002/uog.14684.
(20) Manappallil, R. G.; Kokoori, S. V.; Valsala, N. Severe Ovarian Hyperstimulation Syndrome despite Low Dose Stimulation in Polycystic Ovarian Syndrome. Asian J. Med. Sci. 2019, 10 (3), рр 50-53. https://doi.org/10.3126/ajms.v10i3.22728.
(21) Законодавство України. Про організацію амбулаторної акушерсько-гінекологічної допомоги в Україні. https://zakon.rada.gov.ua/rada/show/v0417282-11 (редакція від 13.04.2016).
(22) Законодавство України. Гельсінська декларація Всесвітньої медичної асоціації "Етичні принципи медичних досліджень за участю людини у якості об'єкта дослідження". https://zakon.rada.gov.ua/laws/show/990_005 (редакція від 01.10.2008).
(23) Законодавство України. Конвенція про захист прав людини і основоположних свобод. https://zakon.rada.gov.ua/laws/show/995_004 (редакція від 02.10.2013).
(24) Авраменко, Н. В.; Кабаченко, О. В.; Барковський, Д. Є.; В, К. В. Загальноклінічні, Біохімічні Показники Та Рівень Гормонів Периферичної Крові Жінок в Умовах Синдрому Гіперстимуляції Яєчників. Міжнародний медичний журнал 2018, 2, 41–45.
(25) Егорова, Е. А.; Терентьева, А. П. Синдром Гиперстимуляции Яичников (Обзор Литературы и Клиническое Наблюдение). Радиология 2015, 3 (51), c 29-36.
(26) Balk, R. A. Systemic Inflammatory Response Syndrome (SIRS): Where Did It Come from and Is It Still Relevant Today? Virulence. 2014, pp 20-26. https://doi.org/10.4161/viru.27135.
(27) Аншина, М. Б.; Исакова, Э. В.; Калинина, Е. А.; Калинина, Е. А.; Корнеева, И. Е.; Корсак, В. С.; Назаренко, Т. А., Смольникова, В. Ю. Синдром Гиперстимуляции Яичников. Клинические Рекомендации. Репродуктивная медицина 2013, 2 (15), c 33-44.
(28) Силява, В. Л.; Гуляева, Л. С.; Прасмыцкий, О. Т. Тяжелый Синдром Гиперстимуляции Яичников При Раннем Сроке Беременности. Медицинский журнал БДМУ 2012, 4, c 129-130.
(29) Lainas, G. T.; Lainas, T. G.; Venetis, C. A.; Sfontouris, I. A.; Zorzovilis, I. Z.; Alexopoulou, E.; Tarlatzis, B. C.; Kolibianakis, E. M. Ultrasound and Hematological Changes during Early Luteal Phase in Women at High Risk for Developing Ovarian Hyperstimulation Syndrome. Ultrasound Obstet. Gynecol. 2018, 51 (1), рр 126-133. https://doi.org/10.1002/uog.18949.
(30) Корнеева, И. Е.; Сароян, Т. Т.; Калинина, Е. А.; Смольникова, В. Ю. Синдром Гиперстимуляции Яичников: Этиопатогенез, Клиника, Диагностика (Часть 1). Акушерство и Гинекология 2013, 7, c 8-13.
(31) Протопопова, Н. В.; Дружинина, Е. Б.; Мыльникова, Ю. В.; Болдонова, Н. А.; Свхьянова, Н. Л. Факторы Риска и Критерии Прогнозирования Синдрома Гиперстимуляции Яичников. Бюллетень ВСНЦ СО РАМН 2012, 3 (85), c 65-70.
(32) Budev, M. M.; Arroliga, A. C.; Falcone, T. Ovarian Hyperstimulation Syndrome. CE.ritical Care Med. 2005, 33 (10), pp 301-306. https://doi.org/10.1097/01.CCM.0000182795.31757.CE.
(33) Jahromi, B. N.; Parsanezhad, M. E.; Shomali, Z.; Bakhshai, P.; Alborzi, M.; Vaziri, N. M.; Anvar, Z. Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management. Iran. J. Med. Sci. 2018, 43 (3), pp 248-260.
How to Cite
Bekasova, O. F., Avramenko, N. V., Kabachenko, O. V., Ivanova, K. D., & Kopiika, V. V. (1). Peripheral blood indices in women with development of ovarian hyperstimulation syndrome. Bulletin of Zaporizhzhia National University. Biological Sciences, (1), 14-22. https://doi.org/10.26661/2410-0943-2019-1-02